Trials / Recruiting
RecruitingNCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Tissue Procurement For Hematolymphoid Conditions
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 15,000 (estimated)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.
Detailed description
OBJECTIVES: * Provide source of patient tissue, blood, and body fluid samples for ongoing diagnostic, prognostic, or immune-monitoring studies. * Support and enhance translational, clinical and basic research for Lineberger Comprehensive Cancer Center (LCCC) members (and non-members who have an LCCC member as sponsor and collaborator) with IRB-approved studies. * Maintain responsible and appropriate policies and procedures that ensure good patient care and responsible conduct of research. * Address medical and legal issues, and protect participant and patient privacy and confidentiality. * Provide a responsible and uniform mechanism for the integrated coordination of the hemato-pathologist and surgeon or hematology/oncology staff, researcher, and protocol office to obtain appropriate specimens for researchers. * Support young investigators to obtain pilot data for grant funding. OUTLINE: Patients undergo tissue, blood, and body fluid collection during diagnostic or routine procedures for future correlative studies. Tissue samples may include, but are not limited to, lymph node or non-nodal biopsies, bone marrow biopsy and/or aspirate, blood and serum, and buccal swabs for germline DNA analysis.
Conditions
- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Lymphoproliferative Disorder
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms
- Nonmalignant Neoplasm
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | biologic sample preservation procedure | All samples collected during routine clinical care. |
| OTHER | cytology specimen collection procedure | All Samples collected during routine clinical care. |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2040-07-01
- Completion
- 2040-07-01
- First posted
- 2010-06-04
- Last updated
- 2025-10-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01137643. Inclusion in this directory is not an endorsement.